Citation 73485

MIMAKI,Y: NAKAMURA,O: SASHIDA,Y: SATOMI,Y: NISHINO,A: NISHINO,H:. (1994). STEROIDAL SAPONINS FROM THE BULBS OF LILIUM LONGIFLORUM AND THEIR ANTITUMOUR-PROMOTER ACTIVITY.. 37(1)

Citation Details

Title	STEROIDAL SAPONINS FROM THE BULBS OF LILIUM LONGIFLORUM AND THEIR ANTITUMOUR-PROMOTER ACTIVITY.
Authors	MIMAKI,Y: NAKAMURA,O: SASHIDA,Y: SATOMI,Y: NISHINO,A: NISHINO,H:
Year	1994
Volume	37
Issue	1

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Lilium longiflorum (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-EN-3-BETA-OL,25(R): 26(R)-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSIDE(1-4)]-BETA-D-GLUCOPYRANOSIDE]	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SPIROST-5-EN-3-BETA-OL,25(R): 26(R)-METHOXY: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSIDE(1-4)]-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-ENE-3-BETA-27-DIOL,25(S): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	None
4	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-27-DIOL,25(S): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	WEAK ACTIVITY
5	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-ENE-3-BETA-27-DIOL,25(R): 27-O-[3(S)-HYDROXY-3-METHYL-GLUTARYL]: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	None
6	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-27-DIOL,25(R): 27-O-[3(S)-HYDROXY-3-METHYL-GLUTARYL]: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SPIROST-5-EN-3-BETA-OL,25(R): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SPIROST-5-EN-3-BETA-OL,25(R): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROST-5-ENE-3-BETA-27-DIOL,25(S): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	None
10	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-27-DIOL,25(S): 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	EQUIVOCAL
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROST-5-ENE-3-BETA-27-DIOL,25(R): 27-O-[3(S)-HYDROXY-3-METHYL-GLUTARYL]: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	None
12	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE-3-BETA-27-DIOL,25(R): 27-O-[3(S)-HYDROXY-3-METHYL-GLUTARYL]: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	None
14	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	None
16	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[ALPHA-L-ARABINOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
17	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	None
18	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROST-5-ENE-3-BETA-22-EPSILON-26-TRIOL,25(R): 22-O-METHYL-26-O-BETA-D-GLUCOPYRANOSYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-BETA-D-GLUCOPYRANOSIDE]	INACTIVE

Show SPARQL Queries (1)